Literature DB >> 30770355

Outcomes of small-gauge vitreoretinal surgery without scleral-depressed shaving of the vitreous base in the era of wide-angle viewing systems.

Homayoun Tabandeh1, Nikolas J S London2, David S Boyer3, Harry W Flynn4.   

Abstract

PURPOSE: To evaluate outcomes of small-gauge pars plana vitrectomy (PPV) for the treatment of rhegmatogenous retinal detachment (RD) without scleral-depressed shaving of the vitreous base.
METHODS: Retrospective, consecutive case series. Surgical technique included small-gauge PPV (25G, 23G, 25G+ or 27G) and wide-angle vitrectomy viewing system in all cases. No cases were excluded based on the level of complexity of RD. Outcome measures were retinal reattachment rates and Snellen visual acuity (best-corrected visual activity [BCVA]).
RESULTS: 312 eyes of 301 patients, mean age 60.8 years, and mean follow-up 23.1 months. Baseline characteristics included macula-off RD in 207 (66%) eyes, psudophakia in 124 (40%) eyes, high myopia in 74 (24%) eyes and giant retinal tear in 14 (5%) eyes. The retina was reattached with one procedure in 296 (95%) eyes. Final retinal reattachment was achieved in 310 (99%) eyes. The BCVA at baseline was >20/40 in 76 (24%) eyes, 20/50-20/100 in 48 (15%) eyes, 20/200-20/400 in 46 (15%) eyes and <20/400 in 142 (46%) eyes. At the last follow-up, the BCVA was >20/40 in 168 (54%) eyes, 20/50-20/100 in 60 (19%) eyes, 20/200-20/400 in 49 (16%) eyes and <20/400 in 35 (11%) eyes. The mean change in logMAR equivalent was -0.12 for the macula-on group and -1.13 for the macula-off group (p<0.0001).
CONCLUSION: Small-gauge PPV without scleral-depressed vitreous base shaving can be associated with good anatomical and visual outcomes. Case selection based on the complexity of RD may not be required when considering small-gauge PPV. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  23 25 and 27 gauge vitrectomy; microincision small gauge pars plana vitrectomy; retinal detachment; scleral depression; vitreous shave

Mesh:

Year:  2019        PMID: 30770355     DOI: 10.1136/bjophthalmol-2018-313626

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  6 in total

1.  Quantification of the peripheral vitreous after vitreous shaving using intraoperative optical coherence tomography.

Authors:  Koichi Nishitsuka; Katsuhiro Nishi; Hiroyuki Namba; Yutaka Kaneko; Hidetoshi Yamashita
Journal:  BMJ Open Ophthalmol       Date:  2021-02-17

2.  Evaluation of long-term outcomes associated with extended heavy-silicone oil use for the treatment of inferior retinal detachment.

Authors:  Fatih Horozoglu; Hidayet Sener; Osman Ahmet Polat; Ozkan Sever; Busra Potoglu; Erkan Celik; Elif Betul Turkoglu; Cem Evereklioglu
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

3.  Localized versus 360-degree laser photocoagulation with limited pars plana vitrectomy in the management of primary rhegmatogenous retinal detachment.

Authors:  Na-Kyung Ryoo; So Yeon Kim; Se Joon Woo; Kyu Hyung Park
Journal:  BMC Ophthalmol       Date:  2022-10-07       Impact factor: 2.086

4.  Surgical Outcomes of Rhegmatogenous Retinal Detachment with Different Peripheral Vitreous-Shaving Procedures.

Authors:  Koichi Nishitsuka; Madoka Nakamura; Katsuhiro Nishi; Hiroyuki Namba; Yutaka Kaneko; Hidetoshi Yamashita
Journal:  Clin Ophthalmol       Date:  2021-05-28

5.  Protective Role of 360° Laser Retinopexy in Patients with Rhegmatogenous Retinal Detachment: a Systematic Review and Meta-analysis.

Authors:  Christa Soekamto; Edward R Chu; Daniel A Johnson; Jeong-Hyeon Sohn; Sepehr Bahadorani
Journal:  Korean J Ophthalmol       Date:  2021-06-04

6.  Real-life comparison of the viewing angle and the image quality of two commonly used viewing systems for vitreoretinal surgery

Authors:  Kemal Bayrakçeken; Ahmet Murad Hondur; Hatice Tuba Atalay; Yavuz Kemal Aribaş
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.